LADENBURG THALMANN FINANCIAL SERVICES INC. - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 90 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q1 2017. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q2 2019$1,000
-75.0%
3,0000.0%0.00%
Q1 2019$4,000
+33.3%
3,0000.0%0.00%
Q4 2018$3,000
-62.5%
3,0000.0%0.00%
Q3 2018$8,000
-11.1%
3,0000.0%0.00%
Q2 2018$9,0000.0%3,0000.0%0.00%
Q1 2018$9,000
-52.6%
3,0000.0%0.00%
Q4 2017$19,000
-9.5%
3,0000.0%0.00%
Q3 2017$21,0000.0%3,0000.0%0.00%
Q2 2017$21,000
-63.8%
3,000
-52.0%
0.00%
-100.0%
Q1 2017$58,000
+132.0%
6,2500.0%0.00%
Q4 2016$25,000
+127.3%
6,250
+108.3%
0.00%
Q3 2016$11,000
-15.4%
3,0000.0%0.00%
Q2 2016$13,000
-7.1%
3,000
-2.3%
0.00%
Q1 2016$14,000
-54.8%
3,0720.0%0.00%
-100.0%
Q4 2015$31,000
+34.8%
3,0720.0%0.00%
Q3 2015$23,000
+187.5%
3,072
+1686.0%
0.00%
Q2 2015$8,000
+33.3%
1720.0%0.00%
Q1 2015$6,000
-14.3%
1720.0%0.00%
Q4 2014$7,000
+133.3%
1720.0%0.00%
Q3 2014$3,000
+50.0%
1720.0%0.00%
Q2 2014$2,000
+100.0%
172
+72.0%
0.00%
Q1 2014$1,0000.0%1000.0%0.00%
Q4 2013$1,0001000.00%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q1 2017
NameSharesValueWeighting ↓
Opaleye Management Inc. 330,000$2,353,0000.98%
EcoR1 Capital, LLC 633,400$4,516,0000.80%
DLD Asset Management, LP 570,000$4,059,0000.53%
Rhenman & Partners Asset Management AB 300,000$2,139,0000.31%
Eventide Asset Management 600,000$4,278,0000.27%
Tekla Capital Management LLC 1,004,322$7,161,0000.26%
Rock Springs Capital Management LP 698,000$4,977,0000.25%
DLD Asset Management, LP 230,000$1,640,0000.21%
Worth Venture Partners, LLC 29,325$209,0000.18%
Crestline Management, LP 161,403$1,151,0000.15%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders